Reprint

Aging and Age-related Disorders: From Molecular Mechanisms to Therapies

Edited by
August 2019
322 pages
  • ISBN978-3-03921-355-9 (Paperback)
  • ISBN978-3-03921-356-6 (PDF)

This book is a reprint of the Special Issue Aging and Age-related Disorders: From Molecular Mechanisms to Therapies that was published in

Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary
Aging of unicellular and multicellular eukaryotic organisms is a convoluted biological phenomenon, which is manifested as an age-related functional decline caused by progressive dysregulation of certain cellular and organismal processes. Many chronic diseases are associated with human aging. These aging-associated diseases include cardiovascular diseases, chronic obstructive pulmonary disease, chronic kidney disease, diabetes, osteoarthritis, osteoporosis, sarcopenia, stroke, neurodegenerative diseases (including Parkinson’s, Alzheimer’s, and Huntington’s diseases), and many forms of cancer. Studies in yeast, roundworms, fruit flies, fishes, mice, primates, and humans have provided evidence that the major aspects and basic mechanisms of aging and aging-associated pathology are conserved across phyla. The focus of this International Journal of Molecular Sciences Special Issue is on molecular and cellular mechanisms, diagnostics, and therapies and diseases of aging. Fifteen original research and review articles in this Special Issue provide important insights into how various genetic, dietary, and pharmacological interventions can affect certain longevity-defining cellular and organismal processes to delay aging and postpone the onset of age-related pathologies in evolutionarily diverse organisms. These articles outline the most important unanswered questions and directions for future research in the vibrant and rapidly evolving fields of mechanisms of biological aging, aging-associated diseases, and aging-delaying therapies.
Format
  • Paperback
License
© 2019 by the authors; CC BY-NC-ND license
Keywords
advanced glycated end products; aging; diabetes; electron microscopy; nanomedicine; ribose; reconstructed human skin; skin absorption; circadian; immunosenescence; inflammaging; melatonin; microRNAs; sirtuin-1; hematopoietic stem cell aging; rejuvenation; self-renewal; differentiation; blood–brain barrier; aging; inflammation; aging-related disorders; longevity genes; arterial aging; low-dose fluvastatin and valsartan combination; cell cycle; cellular quiescence; mechanisms of quiescence maintenance; mechanisms of quiescence entry and exit; adult stem cells; metabolism; mitochondria; reactive oxygen species; cell signaling; proteostasis; GSK3 (glycogen synthase kinase 3); protein kinases; transcription; lifespan; the nervous system; Drosophila melanogaster; n/a